Hacker News
new
|
past
|
comments
|
ask
|
show
|
jobs
|
submit
login
xibalba
on Jan 21, 2022
|
parent
|
context
|
favorite
| on:
Alphabet's Calico has begun trials on a molecule f...
I imagine some number of them endured brain damage as part of the increasingly acrobatic nature of that "challenge". So maybe they will be downstream beneficiaries to the extent this drug's development advances the field of neural regeneration.
Join us for
AI Startup School
this June 16-17 in San Francisco!
Guidelines
|
FAQ
|
Lists
|
API
|
Security
|
Legal
|
Apply to YC
|
Contact
Search: